Viatris' generic of Symbicort (budesonide and formoterol ... Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy.
The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...
A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper ... with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously ...
Similarly, AstraZeneca’s blockbuster drug Symbicort is only now facing a generic competitor, nearly 20 years after its 2006 launch. The inhaler has been widely prescribed because it contains a ...
The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could ...
The inhaler cleared the FDA’s desk in ... Last August, Viatris and Kindeva Drug Delivery launched the first Symbicort copycat in the U.S. under the brand name Breyna. Breyna is indicated for ...
Global Dyspnea Treatment MarketThe global dyspnea treatment market, valued at USD 5.90 billion in 2022, is expected to experience robust growth, projected to reach approximately USD 12.3 billion by ...
Gemtesa (vibegron) is a prescription drug used to treat symptoms of overactive bladder (OAB). Gemtesa can cause side effects that range from mild to serious. Examples include headache, nausea ...
Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...
Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Synthesis and ...